Telaprevir - CAS# 402957-28-2 Catalog No.:M10865-2 the proteosome-mediated enzymatic degradation of
USD90.00
USD120.00
Pay in 4 interest-free payments of $22.50 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Live Spec
Telaprevir - CAS# 402957-28-2 Catalog No.:M10865-2 the proteosome-mediated enzymatic degradation ofTelaprevir (VX 950), marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors. Specifically, telaprevir inhibits the hepatitis C viral enzyme NS3. 4A serine protease. Telaprevir is only indicated for use against hepatitis C genotype 1 viral infections and has not
Store: havirskybal.cz · Domain: havirskybal.cz
